BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, July 14, 2026
Home
»
Authors
»
Rainer B. Langen
Articles by Rainer B. Langen
Co.don Taking Cell Platform Public On Market In Germany
Feb. 7, 2001
By
Rainer B. Langen
German Government Commits DM1.5B To Biotech Research
Jan. 31, 2001
By
Rainer B. Langen
GPC, Byk Gulden Collaborate In Deal Worth Up To US$100M
Jan. 24, 2001
By
Rainer B. Langen
MorphoSys Enters EUR22M Deal With Centocor Around HuCAL
Jan. 10, 2001
By
Rainer B. Langen
Xantos Formed Around Platform To Perform Functional Genomics
Jan. 10, 2001
By
Rainer B. Langen
MediGene's Genital Warts Drug Enters Phase III Clinical Trials
Jan. 10, 2001
By
Rainer B. Langen
LION Adds Preclinical Capability Through $35M Trega Acquisition
Jan. 3, 2001
By
Rainer B. Langen
Estonia Will Build National Gene Bank With SNPs Of 1M Citizens
Jan. 3, 2001
By
Rainer B. Langen
Germans React To British Decision On Embryonic Stem Cell Cloning
Jan. 3, 2001
By
Rainer B. Langen
Previous
1
2
3
4
Next
